32.15
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché RARE Giù?
Forum
Previsione
Frazionamento azionario
Ultragenyx Pharmaceutical Inc Borsa (RARE) Ultime notizie
Will Ultragenyx Pharmaceutical Inc. stock benefit from upcoming earnings reportsWeekly Gains Report & Smart Swing Trading Techniques - newser.com
Will Ultragenyx Pharmaceutical Inc. see short term momentumBuy Signal & Momentum Based Trading Ideas - newser.com
Does Ultragenyx Pharmaceutical Inc. fit your quant trading modelJuly 2025 Sector Moves & Short-Term Swing Trade Alerts - newser.com
Sentiment analysis tools applied to Ultragenyx Pharmaceutical Inc.Market Sentiment Review & Safe Capital Growth Stock Tips - newser.com
Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
Can Ultragenyx Pharmaceutical Inc. (UP0) stock hold up in economic slowdownJuly 2025 WrapUp & AI Forecast for Swing Trade Picks - newser.com
Ultragenyx Pharmaceutical Inc. stock prediction for this weekWeekly Trade Review & Reliable Trade Execution Plans - newser.com
What sentiment indicators say about Ultragenyx Pharmaceutical Inc. stockCPI Data & Capital Protection Trade Alerts - newser.com
Weiss Ratings Reiterates Sell (E+) Rating for Ultragenyx Pharmaceutical (NASDAQ:RARE) - MarketBeat
What moving averages say about Ultragenyx Pharmaceutical Inc.2025 Technical Overview & Free Weekly Watchlist of Top Performers - newser.com
Does Ultragenyx Pharmaceutical Inc. show high probability of reboundWeekly Risk Report & Advanced Swing Trade Entry Plans - newser.com
Predicting Ultragenyx Pharmaceutical Inc. trend using moving averagesJuly 2025 Chart Watch & Safe Entry Point Identification - newser.com
What drives Ultragenyx Pharmaceutical Inc stock priceTechnical Analysis Insights & Hidden Gems with Outstanding Profit Margins - earlytimes.in
Wealth Enhancement Advisory Services LLC Takes $353,000 Position in Ultragenyx Pharmaceutical Inc. $RARE - MarketBeat
Bank of America Securities Remains Bullish on Ultragenyx Pharmaceutical (RARE) - Yahoo Finance
Pattern recognition hints at Ultragenyx Pharmaceutical Inc. upsideWeekly Volume Report & High Conviction Buy Zone Picks - newser.com
Why Ultragenyx Pharmaceutical Inc. (UP0) stock signals breakout potentialJuly 2025 WrapUp & Real-Time Volume Trigger Notifications - newser.com
How to read the order book for Ultragenyx Pharmaceutical Inc.Share Buyback & Free Daily Entry Point Trade Alerts - newser.com
Ultragenyx Pharmaceutical Inc. stock trend outlook and recovery path2025 Key Lessons & Weekly High Potential Stock Alerts - newser.com
Will Ultragenyx Pharmaceutical Inc. (UP0) stock outperform energy sector in 2025Watch List & High Accuracy Swing Entry Alerts - newser.com
BofA Securities Maintains Ultragenyx Pharmaceutical(RARE.US) With Buy Rating, Maintains Target Price $80 - 富途牛牛
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
62,232 Options & 34,564 RSUs: Ultragenyx Grants Inducement Award to New Hire, Grant Date Sep 30, 2025 - Stock Titan
Ultragenyx Pharmaceutical (RARE): Valuation Perspectives Following Regulatory Milestones and Pipeline Progress - Yahoo Finance
Ultragenyx Pharmaceutical (RARE): Evaluating Valuation After Strategic Leadership Transition with Eric Olson - Sahm
Using RSI to spot recovery in Ultragenyx Pharmaceutical Inc.Weekly Investment Recap & Smart Money Movement Tracker - newser.com
Tools to monitor Ultragenyx Pharmaceutical Inc. recovery probabilityAnalyst Downgrade & Precise Swing Trade Entry Alerts - newser.com
How to monitor Ultragenyx Pharmaceutical Inc. with trend dashboards2025 Short Interest & High Return Trade Guides - newser.com
How Might Ultragenyx (RARE) Leverage Dealmaking Expertise to Shape Its Long-Term Growth Strategy? - Yahoo Finance
Ultragenyx (RARE) Poised for Positive Developments, Says JPMorga - GuruFocus
Assenagon Boosts Ultragenyx Pharmaceutical Inc. (RARE) Stake by 439% Amid Breakthrough Pipeline - Insider Monkey
Mucopolysaccharidosis III Pipeline 2025: Pioneering Clinical - openPR.com
Mucopolysaccharidosis III Pipeline 2025: Pioneering Clinical Progress by 8+ Global Leaders – DelveInsight | Featuring Ultragenyx Pharmaceutical Inc, JCR Pharmaceuticals Co., Ltd., GC Biopharma Corp, D - The Globe and Mail
Ultragenyx Pharmaceutical Hits Day High with Strong 8.12% Intraday Surge - Markets Mojo
Ultragenyx Pharmaceutical Experiences Revision in Stock Evaluation Amid Market Dynamics - Markets Mojo
United States Osteogenesis Imperfecta Treatment Market - openPR.com
Ultragenyx appoints Eric Olson as chief business officer By Investing.com - Investing.com Nigeria
Revolution Medicines hires Mirati, ALX vet Sandler - biocentury.com
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):